The mammography market would grow at a CAGR of 8.01% over the predicted time frame. The market is expected to increase in value from US$ 2.59 Bn in 2022 to US$ 4.8 Bn in 2030.
Key Takeaways:
- By product, U.S. mammography market was valued at USD 659 million in 2021 and is registering growth at a CAGR of 9.7% from 2022 to 2030.
- North America ruled the market and represented the biggest share of around 42% in 2021.
- The breast tomosynthesis technology segment is projected to grow at a CAGR of 6.3% from 2022 to 2030.
- By technology, the digital mammography innovation segment accounted 68% revenue share in 2021.
- By product, the digital systems segment has garnered 62% market share in 2021.
- The 3D systems product segment is expected to reach at a 8.4% over the forecast period.
The on mammography Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/1854
Report Scope of the Mammography Market
| Report Coverage | Details |
| Market Size by 2030 | USD 4.8 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 8.01% |
| North America Market Share in 2021 | 42% |
| Digital Mammography Innovation Segment Market Share in 2021 | 68% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Technology, Modality, End Use, Geography |
A recent report provides crucial insights along with application based and forecast information in the Global Mammography Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Mammography market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Mammography market are included as given below:
Mammography Market Key Players
- Hologic
- Fujifilm
- Siemens Healthcare
- Phillips Healthcare
- Toshiba Medical Systems
- GE Healthcare
- Metaltronica
- I.M.S. Srl
- Koninklijke Philips NV
- Gamma Medica, Inc.
- Konica Minolta Business Solutions India Private Limited
- Carestream Health.
- BMI Biomedical International SRL
- Canon Inc
- MetaltronicaSpA, PLANNED OY
- GENERAL MEDICAL ITALIA
- Villa Systems Medical SpA
Market Segments
By Product
- Film Screen Systems
- Digital Systems
- Analog Systems
- Biopsy Systems
- 3D Systems
- Others
By Technology
- Breast Tomosynthesis Mammography
- CAD Mammography
- Digital Mammography
By Modality
- Portable
- Non-Portable
By End Use
- Hospitals
- Special Clinics
- Diagnosis Centers
- Ambulatory Surgical Centers
- Educational & Research Institutes
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global mammography market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the mammography market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Mammography Market
5.1. COVID-19 Landscape: Mammography Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Mammography Market, By Product
8.1. Mammography Market, by Product, 2022-2030
8.1.1. Film Screen Systems
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Digital Systems
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Analog Systems
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Biopsy Systems
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. 3D Systems
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Mammography Market, By Technology
9.1. Mammography Market, by Technology e, 2022-2030
9.1.1. Breast Tomosynthesis Mammography
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. CAD Mammography
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Digital Mammography
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Mammography Market, By Modality
10.1. Mammography Market, by Modality, 2022-2030
10.1.1. Portable
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Non-Portable
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Mammography Market, By End Use
11.1. Mammography Market, by End Use, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Special Clinics
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Diagnosis Centers
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Ambulatory Surgical Centers
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Educational & Research Institutes
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Mammography Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.3. Market Revenue and Forecast, by Modality (2017-2030)
12.1.4. Market Revenue and Forecast, by End Use (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End Use (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End Use (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End Use (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End Use (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End Use (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End Use (2017-2030)
Chapter 13. Company Profiles
13.1. Hologic
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Fujifilm
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Siemens Healthcare
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Phillips Healthcare
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Toshiba Medical Systems
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GE Healthcare
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Metaltronica
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. I.M.S. Srl
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Koninklijke Philips NV
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Gamma Medica, Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments